Director Hopfner Robert Lorne bought Evommune Inc. ($EVMN) shares once on the open market in the last year, totaling $17,350, with the latest purchase on December 19, 2025. His buying ranks 3,951st among 4,983 insiders, below the average of $1.46 million per buyer and 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Director | P | Common Stock | 1000 | $17.35 | 3,372,001.0000 | 31,524,093 | 0.03% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series Seed Preferred Stock | 3572816 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series C Preferred Stock | 313571 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series C Preferred Stock | 313571 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series C Preferred Stock | 2508575 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Common Stock | 3026 | $0.00 | 3,371,001.0000 | 0 | 0.09% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Common Stock | 1441032 | $0.00 | 3,371,001.0000 | 0 | 74.67% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Common Stock | 1632441 | $0.00 | 3,371,001.0000 | 0 | 93.90% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Common Stock | 294502 | $0.00 | 3,371,001.0000 | 0 | 9.57% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series Seed Preferred Stock | 25790 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series Seed Preferred Stock | 7145647 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series A Preferred Stock | 2582243 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series A Preferred Stock | 7230283 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series B Preferred Stock | 1895260 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | Hopfner Robert Lorne | Not found | C | Series B Preferred Stock | 2104740 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 13, 2025 | Rallybio Corp | $RLYB | Hopfner Robert Lorne | Director | A | Option (Right to Buy) | 28500 | $0.00 | 28,500.0000 | 43,544,824 | 9999.99% | 0.07% |
| Jan. 2, 2025 | Rallybio Corp | $RLYB | Hopfner Robert Lorne | Director | A | Option (Right to Buy) | 73571 | $0.70 | 73,571.0000 | 43,544,824 | 9999.99% | 0.17% |
| May 15, 2024 | Rallybio Corp | $RLYB | Hopfner Robert Lorne | Director | A | Option (Right to Buy) | 16500 | $0.00 | 16,500.0000 | 40,447,388 | 9999.99% | 0.04% |